Evidence map›Paper›PMID 39375806›Full record

ArticleGenome medicine2024

High density genomic surveillance and risk profiling of clinical Listeria monocytogenes subtypes in Germany.

Sven Halbedel, Sabrina Wamp, Raskit Lachmann, Alexandra Holzer, Ariane Pietzka, Werner Ruppitsch, Hendrik Wilking, Antje Flieger

Abstract read
In one paragraph

Article in Genome medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. AEmerging microbes & infections · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Closed genome sequences of clinicalMicrobiology resource announcements · 2026
    Article
  6. Phage P100 resistance in clinical and foodborneCurrent research in microbial sciences · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Outbreak of listeriosis associated with consumption of deli meats in a hospital, Germany, February to March 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  11. Integrating Bacteriocins and Biofilm-Degrading Enzymes to EliminateInternational journal of molecular sciences · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sven Halbedel *FG11 Division of Enteropathogenic Bacteria and Legionella, Consultant Laboratory for Listeria, Robert Koch Institute, Burgstrasse 37, Wernigerode, D-38855, Germany. halbedels@rki.de.ORCID 0000-0002-5575-8973
Sabrina Wamp *FG11 Division of Enteropathogenic Bacteria and Legionella, Consultant Laboratory for Listeria, Robert Koch Institute, Burgstrasse 37, Wernigerode, D-38855, Germany.
Raskit LachmannFG35 - Division for Gastrointestinal Infections, Zoonoses and Tropical Infections, Robert Koch Institute, Seestrasse 10, Berlin, 13353, Germany.
Alexandra HolzerFG35 - Division for Gastrointestinal Infections, Zoonoses and Tropical Infections, Robert Koch Institute, Seestrasse 10, Berlin, 13353, Germany.
Ariane PietzkaAustrian Agency for Health and Food Safety, Institute for Medical Microbiology and Hygiene, Beethovenstraße 6, Graz, 8010, Austria.
Werner RuppitschAustrian Agency for Health and Food Safety, Institute for Medical Microbiology and Hygiene, Währingerstrasse 25a, Vienna, 1090, Austria.
Hendrik WilkingFG35 - Division for Gastrointestinal Infections, Zoonoses and Tropical Infections, Robert Koch Institute, Seestrasse 10, Berlin, 13353, Germany.
Antje FliegerFG11 Division of Enteropathogenic Bacteria and Legionella, Consultant Laboratory for Listeria, Robert Koch Institute, Burgstrasse 37, Wernigerode, D-38855, Germany. fliegera@rki.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFoodborne infections such as listeriosis caused by the bacterium Listeria monocytogenes represent a significant public health concern, particularly when outbreaks affect many individuals over prolonged time. Systematic collection of pathogen isolates from infected patients, whole genome sequencing (WGS) and phylogenetic analyses allow recognition and termination of outbreaks after source identification and risk profiling of abundant lineages.

methodsWe here present a multi-dimensional analysis of > 1800 genome sequences from clinical L. monocytogenes isolates collected in Germany between 2018 and 2021. Different WGS-based subtyping methods were used to determine the population structure with its main phylogenetic sublineages as well as for identification of disease clusters. Clinical frequencies of materno-foetal and brain infections and in vitro infection experiments were used for risk profiling of the most abundant sublineages. These sublineages and large disease clusters were further characterised in terms of their genetic and epidemiological properties.

resultsThe collected isolates covered 62% of all notified cases and belonged to 188 infection clusters. Forty-two percent of these clusters were active for > 12 months, 60% generated cases cross-regionally, including 11 multinational clusters. Thirty-seven percent of the clusters were caused by sequence type (ST) ST6, ST8 and ST1 clones. ST1 was identified as hyper- and ST8, ST14, ST29 as well as ST155 as hypovirulent, while ST6 had average virulence potential. Inactivating mutations were found in several virulence and house-keeping genes, particularly in hypovirulent STs.

conclusionsOur work presents an in-depth analysis of the genomic characteristics of L. monocytogenes isolates that cause disease in Germany. It supports prioritisation of disease clusters for epidemiological investigations and reinforces the need to analyse the mechanisms underlying hyper- and hypovirulence.

Indexed as

GenomicsListeria monocytogenesListeriosisPhylogenyWhole Genome SequencingDisease OutbreaksFemaleGenome, BacterialGermanyHumansVirulenceclpP1EpidemiologyflaRinlFOutbreak

Identifiers

PMID39375806
PMCPMC11457394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.